ETFs - Profile

iShares Biotechnology ETF

US > Health/Biotechnology >

Rank

Universe Rank
20 14

Summary

The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in companies across any size in the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

The Underlying Index measures the performance of the U.S.-listed equities in the biotechnology sector.

As part of its strategy, the fund employs a passive or indexing approach.

Next, the research team invests significantly in the component securities of its More

Philosophy Strategy Process Reaserch Risk Management

Price

  • Last Close
  • $161.68
    -10.03
  • 52 Week HL
  • $176.21 - $130.19
  • Net Assets
  • $10820 M
  • Expense Ratio

Portfolio

  • Holdings
  • -
  • Turnover Ratio
  • -

Performance
6.7 % YTD

  • 3 Year
  • 67.67%
  • 5 Year
  • 68.43%
  • Best
  • 45.79%
    2003
  • Worst
  • -45.8%
    2002

Returns +
A

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
IBB 7%26%0%0%0%0%0%0%0%0%0%
S&P 500 19%16%29%-6%19%10%-1%11%30%13%0%

Returns +
Q

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Q1 -1.1% -10.4% 15.9% - 10.6% -22.9% 13.2% 4.1% 16.6% 18.2% -
Q2 8% 26.9% -2.5% 7.3% 5.8% -1.3% 7.5% 8.9% 9% 4.6% -
Q3 - - -9.3% 10.2% 7.6% 12.5% -17.8% 6.5% 17.6% 7.5% -
Q4 - 10.8% 20.9% -20.4% -5.3% -8.3% 11.6% 10.9% 8.3% -4.4% -

Returns +
M

J F M A M J J A S O N D
2021 6% -2.5% -4.3% 4.6% -4% 7.5% 2.5% 3.9% -6.2% - - -
2020 -5.4% 0.1% -5.4% 15.1% 8.7% 1.5% 4.2% -4.8% 0.7% -5.1% 11.8% 4.5%

Annual Return

Index Comparison

Alpha

NAV